Genentech taps Halozyme’s tech in Herceptin Hylecta
Genentech receives US FDA approval on Herceptin Hylecta, a subcutaneous co-formulation using Halozyme’s recombinant Enhanze technology, for the treatment of HER2-positive metastatic breast cancer.
Archives for March 5, 2019
Clinical Trials Bot from Microsoft to bolster trial recruitment
The software giant creates Clinical Trials Bot to match patients to clinical trials, as part of its health care bot initiative.
Akorn receives good news after manufacturing network blow
Akorn announces fraud case launched by Fresenius has been denied by US courts, shortly after fourth quarter financials revealed problems within its manufacturing network.
IRB consolidation: Advarra acquires Quorum Review and Kinetiq
The institutional review board industry sees further consolidation as Advarra acquires Quorum and its research and technology consulting division, Kinetiq.
Aurobindo facility receives Form 483 over procedural issues
US FDA issues Form 483 to Aurobindo’s drug product manufacturing plant after it failed to follow sterile procedures.